Currently, the glucagon-like peptide-1 (GLP-1), an endogenous intestinal hormone produced by L-cells of the distal ileum and colon, and its analogues have become one of the promising therapeutic drugs for the treatment of T2DM [6]. Here, GCG is linked to type 2 diabetes mellitus.